Since the inception of the Melanoma Clinic in the early 1960s and the evolution of the Sydney Melanoma Unit, we have led the way with melanoma research, treatment and clinical education. Now with the development of the Melanoma Institute Australia (MIA), the future looks even brighter for the thousands of Australians diagnosed with melanoma each year.

The MIA is an independent, non-profit organisation that is affiliated with the University of Sydney, the Mater Hospital and the Royal Prince Alfred Hospital to improve the outcome of patients with melanoma.

Each year around 1,200 new melanoma patients are referred to the Institute, and approximately 8,000 follow-ups occur. Indeed it has become a major referral centre for melanoma patients in NSW and overseas.

The strength of the MIA is the integrated care that we are able to provide by having a diverse group of specialists who treat melanoma all housed in the same location. This involves not only specialist surgeons treating patients with primary melanomas and recurrent disease, but also specialists in medical oncology, radiation oncology, nuclear medicine, histopathology, radiology, palliative care and oncology nursing. Allowing these diverse relationships to flourish are the mutli-disciplinary meetings that are held every Friday. These meetings are significant in terms of the development of evidence-based treatment policies.